| 000 | 01105 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250518090416.0 | ||
| 264 | 0 | _c20210127 | |
| 008 | 202101s 0 0 eng d | ||
| 022 | _a1527-7755 | ||
| 024 | 7 |
_a10.1200/JCO.19.03318 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aO'Reilly, Eileen M | |
| 245 | 0 | 0 |
_aNeoadjuvant or Adjuvant Therapy for Resectable or Borderline Resectable Pancreatic Cancer: Which Is Preferred? _h[electronic resource] |
| 260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _c06 2020 |
||
| 300 |
_a1757-1759 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Research Support, N.I.H., Extramural; Comment | ||
| 650 | 0 | 4 | _aChemoradiotherapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aNeoadjuvant Therapy |
| 650 | 0 | 4 |
_aPancreatic Neoplasms _xdrug therapy |
| 700 | 1 | _aFerrone, Cristina | |
| 773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 38 _gno. 16 _gp. 1757-1759 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.19.03318 _zAvailable from publisher's website |
| 999 |
_c30693613 _d30693613 |
||